Lidocaine Infusion in Hystroscopy

NCT03825016 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2020-01-28

No results posted yet for this study

Summary

Lidocaine infusion in hystroscopic media versus oral diclofenac

Conditions

Interventions

DRUG

Lidocaine Hydrochloride

Lidocaine infusion on hystroscopic media during office hystroscopy

DRUG

Diclofenac Sodium

Oral Diclofenac Sodium

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2020-01-10
Completion
2020-01-10

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03825016 on ClinicalTrials.gov